A genetically modified opium poppy produces a pharmaceutical precursor instead of morphine and codeine.
References
Allen, R.S. et al. Nat. Biotechnol. 22, 1559–1566 (2004).
Mello, C.C. & Conte D. Jr. Nature 431, 338–342 (2004).
Facchini, P.J. Annu. Rev. Plant Physiol. Plant Mol. Biol. 52, 29–66 (2001).
Memelink, J., Verpoorte, R. & Kijne, J.W. Trends Plant Sci. 6, 212–219 (2001).
De Luca, V. & St. Pierre, B. Trends Plant Sci. 5, 168–173 (2000).
Unterlinner, B., Lenz, R. & Kutchan, T.M. Plant J. 18, 465–475 (1999).
Winkel, B.S.J. Annu. Rev. Plant Biol. 55, 85–107 (2004).
Achnine, L., Blancaflor, E.B., Rasmussen, S. & Dixon, R.A. Plant Cell 16, 3098–3109 (2004).
Bird, D.A., Franceschi, V.R. & Facchini, P.J. Plant Cell 15, 2626–2635 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Memelink, J. Putting the opium in poppy to sleep. Nat Biotechnol 22, 1526–1527 (2004). https://doi.org/10.1038/nbt1204-1526
Issue Date:
DOI: https://doi.org/10.1038/nbt1204-1526
- Springer Nature America, Inc.
This article is cited by
-
Metabolons involving plant cytochrome P450s
Phytochemistry Reviews (2006)
-
EST database for early flower development in California poppy (Eschscholzia californica Cham., Papaveraceae) tags over 6000 genes from a basal eudicot
Plant Molecular Biology (2006)